Table 1. Baseline characteristics of the study participants.
| Treatment (N = 110) | Placebo (N = 111) | p-value | |
|---|---|---|---|
| Age (years) | 54.09 ± 11.012 | 52.93 ± 10.877 | 0.432 |
| Female | 91 (82.73%) | 89 (80.18%) | |
| Height (cm) | 158.95 ± 7.26 | 159.24 ± 8.487 | 0.801 |
| Weight (kg) | 56.91 ± 10.331 | 57.25 ± 9.38 | 0.786 |
| BMI (kg/m2) | 22.45 ± 3.371 | 22.52 ± 3.018 | 0.86 |
| Body temperature (°C) | 36.47 ± 0.304 | 36.5 ± 0.287 | 0.331 |
| Waist circumference (cm) | 80.64 ± 8.843 | 81.83 ± 8.543 | 0.322 |
| Hip circumference (cm) | 95.48 ± 6.696 | 95.21 ± 5.834 | 0.747 |
| LDL-C (mmol/L) | 3.22 ± 0.818 | 3.08 ± 0.779 | 0.197 |
| HDL-C (mmol/L) | 1.53 ± 0.4 | 1.5 ± 0.383 | 0.547 |
| Total cholesterol (mmol/L) | 5.25 ± 0.801 | 5.05 ± 0.682 | 0.056 |
| Triglycerides | 1.21 ± 0.6 | 1.15 ± 0.478 | 0.439 |
| Creatinine (μmol/L) | 65.53 ± 12.239 | 64.34 ± 11.593 | |
| Fasting glucose (mmol/L) | 4.95 ± 0.738 | 4.86 ± 0.464 | 0.301 |
| Systolic blood pressure (mmHg) | 123.35 ± 17.016 | 122.26 ± 16.473 | 0.628 |
| Diastolic blood pressure (mmHg) | 78.86 ± 10.576 | 77.73 ± 9.683 | 0.407 |
Values are given as no. (%) or mean ± SD.